Efficacy and economic impact evaluation of a navigation system for assisted lung biopsy

This Letter reports on the testing and assessment of an optical computed tomography-navigation system for percutaneous lung interventional, SIRIO, showing how the lesion diameter affects the bioptic procedure. Clinical data, relating to 501 patients, were collected at the Department of Interventiona...

Full description

Saved in:
Bibliographic Details
Published inHealthcare technology letters Vol. 5; no. 2; pp. 49 - 53
Main Authors Giannatiempo, Sara, Carpino, Giorgio, Petitti, Tommasangelo, Zobel, Bruno B, Grasso, Rosario F, Guglielmelli, Eugenio
Format Journal Article
LanguageEnglish
Published England The Institution of Engineering and Technology 01.04.2018
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This Letter reports on the testing and assessment of an optical computed tomography-navigation system for percutaneous lung interventional, SIRIO, showing how the lesion diameter affects the bioptic procedure. Clinical data, relating to 501 patients, were collected at the Department of Interventional Radiology of Policlinico Universitario Campus Bio-Medico. This Letter shows that the diameter of lesion affects only the procedure duration (50.91 ± 18.87 min for lesions of diameter ≤20 mm and 44.98 ± 19.43 min for lesions of diameter >20 and ≤40 mm). For the nodules with a diameter ≤20 mm, there is a significant increase in the duration of the procedure (for each mm less the time increases by 6 s). Other parameters like the mean effective radiation dose and the presence of a diagnostic or non-diagnostic specimen do not depend, instead, on the lesion size. The economic analysis based on the biopsy procedure with SIRIO shows the necessity to adopt a new reimbursement system for percutaneous biopsy performed using navigation systems to stimulate their use to get important non-economic gains such as early diagnosis, reduction of the absorbed dose of X-rays and increasing number of lung cancers in a curable early stage.
Bibliography:Giorgio Carpino and Sara Giannatiempo equally contributed to this work and should be considered co‐first authors.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Giorgio Carpino and Sara Giannatiempo equally contributed to this work and should be considered co-first authors.
ISSN:2053-3713
2053-3713
DOI:10.1049/htl.2017.0015